Actinium Pharmaceuticals, Inc.ATNMNYSE
Loading
Year-over-year total asset growth rate
Latest
-10.90%
↓ 176% vs avg
Percentile
P28
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
14.29%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | -10.90% |
| Q2 2025 | -8.20% |
| Q1 2025 | -10.73% |
| Q4 2024 | -6.35% |
| Q3 2024 | -8.62% |
| Q2 2024 | 1.71% |
| Q1 2024 | 8.48% |
| Q4 2023 | -8.43% |
| Q3 2023 | -10.20% |
| Q2 2023 | -2.92% |
| Q1 2023 | -10.65% |
| Q4 2022 | -2.25% |
| Q3 2022 | -4.09% |
| Q2 2022 | 63.35% |
| Q1 2022 | -7.25% |
| Q4 2021 | -4.84% |
| Q3 2021 | 0.03% |
| Q2 2021 | 12.46% |
| Q1 2021 | 13.10% |
| Q4 2020 | 31.41% |
| Q3 2020 | -9.71% |
| Q2 2020 | 569.03% |
| Q1 2020 | -28.33% |
| Q4 2019 | -28.48% |
| Q3 2019 | -25.21% |
| Q2 2019 | 78.33% |
| Q1 2019 | -17.83% |
| Q4 2018 | -5.18% |
| Q3 2018 | -30.47% |
| Q2 2018 | -19.74% |
| Q1 2018 | 53.46% |
| Q4 2017 | -15.58% |
| Q3 2017 | 67.39% |
| Q2 2017 | -28.88% |
| Q1 2017 | -19.02% |
| Q4 2016 | 30.51% |
| Q3 2016 | -19.98% |
| Q2 2016 | -7.59% |
| Q1 2016 | -12.20% |
| Q4 2015 | 6.14% |